Ispire Technology surged 16.05% intraday, driven by its Q1 2026 financial results released on November 12, 2025, showing a 39% year-on-year reduction in operating expenses to $7.8 million and a narrowed net loss of $3.3 million. The company also reported a 29% decrease in net accounts receivable to $44.5 million. Ispire specializes in e-cigarette technology, cannabis vaporization products, and precision dosing solutions, with revenue primarily generated from European markets.
Comments
No comments yet